How does one smile and be cheerful when one wakes up with severely stiff joints and incredible pain? In the conclusion of this two-part series, Lakshmi Menon, 63, talks about the various health issues that arise as Rheumatoid Arthritis (RA) progresses and offers coping mechanisms to maintain best health.
I began to monitor my health condition such as increased pain, swelling or other changes so I could report these developments to my rheumatologist. In the past 8 years, other than pain, morning…

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition